Increased cellular senescence in the murine and human stenotic kidney: Effect of mesenchymal stem cells.
Increased cellular senescence in the murine and human stenotic kidney: Effect of mesenchymal stem cells.
复制标题
小鼠和人狭窄肾细胞衰老增加:间充质干细胞的作用。
DOI:
10.1002/jcp.29940
复制
发表时间:
2021-03
影响因子:
5.6
通讯作者:
Lerman LO
中科院分区:
文献类型:
--
作者:
Kim SR;Zou X;Tang H;Puranik AS;Abumoawad AM;Zhu XY;Hickson LJ;Tchkonia T;Textor SC;Kirkland JL;Lerman LO
Cell stress may give rise to insuperable growth arrest, which is defined as cellular senescence. Stenotic kidney (STK) ischemia and injury induced by renal artery stenosis (RAS) may be associated with cellular senescence. Mesenchymal stem cells (MSCs) decrease some forms of STK injury, but their ability to reverse senescence in RAS remains unknown. We hypothesized that RAS evokes STK senescence, which would be ameliorated by MSCs. Mice were studied after 4 weeks of RAS, RAS treated with adipose tissue-derived MSCs 2 weeks earlier, or sham. STK senescence-associated β-galactosidase (SA-β-Gal) activity was measured. Protein and gene expression was used to assess senescence and the senescence-associated secretory phenotype (SASP), and staining for renal fibrosis, inflammation, and capillary density. Additionally, senescence was assessed as p16+ and p21+ urinary exosomes in patients with renovascular hypertension (RVH) without or 3 months after autologous adipose tissue-derived MSC delivery, and in healthy volunteers (HV). In RAS mice, STK SA-β-Gal activity increased, and senescence and SASP marker expression was markedly elevated. MSCs improved renal function, fibrosis, inflammation, and capillary density, and attenuated SA-β-Gal activity, but most senescence and SASP levels remained unchanged. Congruently, in human RVH, p21+ urinary exosomes were elevated compared to HV, and only slightly improved by MSC, whereas p16+ exosomes remained unchanged. Therefore, RAS triggers renal senescence in both mice and human subjects. MSCs decrease renal injury, but only partly mitigate renal senescence. These observations support exploration of targeted senolytic therapy in RAS.
登录
查看更多内容
影响因子:
7.5
作者:
Ezquer M;Urzua CA;Montecino S;Leal K;Conget P;Ezquer F
通讯作者:
Ezquer F
影响因子:
6.1
作者:
Biancone, Luigi;Bruno, Stefania;Camussi, Giovanni
通讯作者:
Camussi, Giovanni
影响因子:
11.1
作者:
Hickson, LaTonya J.;Prata, Larissa G. P. Langhi;Kirkland, James L.
通讯作者:
Kirkland, James L.
影响因子:
5.2
作者:
Eirin, Alfonso;Zhu, Xiang-Yang;Krier, James D.;Tang, Hui;Jordan, Kyra L.;Grande, Joseph P.;Lerman, Amir;Textor, Stephen C.;Lerman, Lilach O.
通讯作者:
Lerman, Lilach O.
影响因子:
7.5
作者:
Rodrigues CE;Capcha JM;de Bragança AC;Sanches TR;Gouveia PQ;de Oliveira PA;Malheiros DM;Volpini RA;Santinho MA;Santana BA;Calado RD;Noronha IL;Andrade L
通讯作者:
Andrade L